Colgate Palmolive CO Form 4 insider transactions

Director Lisa Edwards acquired 98 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024.

Director John P. Bilbrey acquired 222 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024, through a deferred compensation plan.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, exercised stock options and sold shares on May 14, 2024.

Director John P. Bilbrey reports acquisition of Colgate-Palmolive stock and options as part of an annual director grant.

Director Harris C Martin reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.

Director Martina Hundmejean acquired 1,905 shares of common stock and an option to purchase 2,201 shares of common stock from Colgate-Palmolive on May 13, 2024.

Director Kimberly A Nelson receives stock grant and option award from Colgate-Palmolive.

Director Lorrie M Norrington received an annual stock grant and stock option grant from Colgate-Palmolive on May 13, 2024.

Director Steven A. Cahillane reports receiving stock and option grants from Colgate-Palmolive on May 13, 2024.

Director John T. Cahill reports acquisition of common stock and stock options from Colgate-Palmolive under the company's incentive compensation plan.

Director Lisa Edwards received stock and option grants from Colgate-Palmolive on May 13, 2024, according to a Form 4 filing with the SEC.

Director Brian Newman reports annual stock and option grants from Colgate-Palmolive, along with a clarification regarding shares held in a family trust.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Panagiotis Tsourapas, a Group President at Colgate-Palmolive, exercised stock options and sold shares on May 9, 2024.

John W. Kooyman, Chief of Staff at Colgate-Palmolive, reported the sale of 3,497 shares of common stock on May 7, 2024.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares on May 1, 2024.

Director John P. Bilbrey exercised stock options and sold shares of Colgate-Palmolive common stock on May 1, 2024.

Director John P. Bilbrey acquired 240 shares of Colgate-Palmolive common stock at $88.36 per share on April 1, 2024, through a deferred compensation plan.

Director Lisa Edwards acquired 106 shares of Colgate-Palmolive common stock at $88.36 per share on April 1, 2024.

Director Brian Newman acquired 212 shares of Colgate-Palmolive common stock at $88.36 per share on April 1, 2024, and disposed of 256 shares.

Director Lorrie M Norrington acquired 297 shares of Colgate-Palmolive stock at $88.36 per share on April 1, 2024, according to a Form 4 filing.